Abrilumab, a fully human monoclonal antibody, targets the alpha4beta7 integrin heterodimer, selectively binding to it. This specificity makes it a potential research tool for investigating inflammatory bowel disease (IBD) [1].
CAS Number:
[1342290-43-0]
* VAT and and shipping costs not included. Errors and price changes excepted
